Invesco’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $39.7M | Buy |
4,140,072
+489,260
| +13% | +$4.69M | 0.01% | 1153 |
|
2025
Q1 | $22.9M | Sell |
3,650,812
-20,574
| -0.6% | -$129K | ﹤0.01% | 1369 |
|
2024
Q4 | $29.8M | Sell |
3,671,386
-425,376
| -10% | -$3.45M | 0.01% | 1296 |
|
2024
Q3 | $74.1M | Buy |
4,096,762
+953,310
| +30% | +$17.2M | 0.01% | 890 |
|
2024
Q2 | $32.4M | Sell |
3,143,452
-16,337
| -0.5% | -$168K | 0.01% | 1202 |
|
2024
Q1 | $33.6M | Sell |
3,159,789
-7,864
| -0.2% | -$83.5K | 0.01% | 1211 |
|
2023
Q4 | $28.9M | Sell |
3,167,653
-251,306
| -7% | -$2.29M | 0.01% | 1237 |
|
2023
Q3 | $35.5M | Buy |
3,418,959
+86,822
| +3% | +$900K | 0.01% | 1096 |
|
2023
Q2 | $47.7M | Buy |
3,332,137
+1,150,465
| +53% | +$16.5M | 0.01% | 965 |
|
2023
Q1 | $15.6M | Sell |
2,181,672
-25,977
| -1% | -$185K | ﹤0.01% | 1480 |
|
2022
Q4 | $24.8M | Buy |
2,207,649
+139,781
| +7% | +$1.57M | 0.01% | 1270 |
|
2022
Q3 | $22.9M | Buy |
2,067,868
+21,062
| +1% | +$233K | 0.01% | 1239 |
|
2022
Q2 | $17.3M | Sell |
2,046,806
-2,953
| -0.1% | -$24.9K | 0.01% | 1463 |
|
2022
Q1 | $27.9M | Sell |
2,049,759
-17,597
| -0.9% | -$239K | 0.01% | 1287 |
|
2021
Q4 | $40.7M | Buy |
2,067,356
+71,340
| +4% | +$1.4M | 0.01% | 1138 |
|
2021
Q3 | $64.1M | Sell |
1,996,016
-25,384
| -1% | -$815K | 0.02% | 956 |
|
2021
Q2 | $68.4M | Sell |
2,021,400
-7,531
| -0.4% | -$255K | 0.02% | 954 |
|
2021
Q1 | $76.2M | Sell |
2,028,931
-25,507
| -1% | -$958K | 0.02% | 903 |
|
2020
Q4 | $68.2M | Sell |
2,054,438
-25,749
| -1% | -$855K | 0.02% | 915 |
|
2020
Q3 | $76.3M | Sell |
2,080,187
-15,256
| -0.7% | -$559K | 0.03% | 746 |
|
2020
Q2 | $69M | Buy |
2,095,443
+19,758
| +1% | +$650K | 0.02% | 765 |
|
2020
Q1 | $53.6M | Sell |
2,075,685
-26,618
| -1% | -$687K | 0.02% | 767 |
|
2019
Q4 | $65.5M | Buy |
+2,102,303
| New | +$65.5M | 0.02% | 874 |
|